Term
| Hepatities B Vaccine (HBV) |
|
Definition
| all newborns receive before leaving hospital, High risk infants (those who's mothers are positive for HBsAg, or who's status is unknown) should receive within 12 hours after birth |
|
|
Term
|
Definition
children at age 1, 2 doses administered 6 months apart |
|
|
Term
| Diptheria and Tetanus Toxoids and Pertussis (Killed) Vaccine combined (DTaP) |
|
Definition
Given to children at 2 months, Diptheria and Tetanus are adjuncts to Pertussis, administered at a young age for protection from Pertussis. |
|
|
Term
| Hemophilus Influenzae Type B Conjugate Vaccines (Hib) |
|
Definition
| capsular polysaccharide vaccine. given early because it is largely a pediatric infection |
|
|
Term
| Measles, Mumps, and Rubella Virus Vaccines (Live, attenuated combined) MMR |
|
Definition
Given after 12 months because live viral vaccines do not work well prior to that do not maternal antibodies . Disease follow up because there are problems with controlling measles. |
|
|
Term
| Poliomyelitis Virus Vaccines, Trivalent |
|
Definition
OPV (oral polio vaccine)- "Sabin" no longer used-can actually induce Poliomyelitis IPV- (inactivated polio Vaccine)-"Salk" eliminates the cases of 4 to 5 OPV induced paralytic polio that occured yearly |
|
|
Term
| Varicella Virus (Live Attenuated) |
|
Definition
| prevents chickenpox, 2 doses recommended |
|
|
Term
| Pneumococcal Conjugate Vaccine, 7 Valent (PCV7) |
|
Definition
| children age 2-23 months, the seven serotypes are responsible for more than 80% of invasive disease and more than 65% of acute otitis media. |
|
|
Term
| Pneumococcal Conjugate Vaccine 23 Valent (PCV23) |
|
Definition
| children greater than or 2 years of age who are high risk, ex: sickle cell anemia, HIV infection, immunocompromising or chronic conditions |
|
|
Term
|
Definition
annual immunization recommended for children 6-59 months Live Nasal Vaccine: 2-49 years of age (healthy) Inactivated Vaccine: children < 2yrs and high risk individuals |
|
|
Term
| Rotovirus Vaccine, Live Oral Tetravalent |
|
Definition
rotavirus leading cause of gastroenteritis, old vaccine removed from market for causing intussusception. New Vaccine(2007): 1st dose should be administered at 6-12 weeks. Exception to the rule of NOT administering live vaccine to children under 12 months |
|
|
Term
| Meningococcal Conjugate Vaccine |
|
Definition
conjugate polysaccharide high risk children, adolescents who live in close quarters, can occur in epidemics |
|
|
Term
Vaccinia Vaccine (Smallpox Vaccine) |
|
Definition
last case of smallpox in 1977. most successful vaccine |
|
|
Term
| Human Papillomavirus Vaccine |
|
Definition
| protects against 4 strains of HPV most commonly found in precancerous lesions of the cervix |
|
|
Term
|
Definition
mab, inhibits binding of IgE to mast cells/basophils, reduces Fc receptors on basophils |
|
|
Term
|
Definition
| mab, anticoagulant, IgG Fab segment specific for glycoproteins IIb/IIIa of platelets |
|
|
Term
|
Definition
|
|
Term
|
Definition
mab, treatment of acute digoxin intoxication |
|
|
Term
|
Definition
| immunosuppressive mab, specific for IL2 receptor subunit CD25. prophylaxis of acute renal transplantation rejection |
|
|
Term
|
Definition
| immunosuppressive mab, specific for IL2 receptor subunit CD25. prophylaxis of acute renal transplantation rejection |
|
|
Term
|
Definition
| specific for CD3 on T cells (less specific immunosuppressive mab) prophylaxis of acute renal transplantation rejection |
|
|
Term
|
Definition
cytokine lot of endocrine bc of its erythropoient qualities, acts largely on bone marrow, indicated for treatment of anemia assoc. with chronic renal failure. |
|
|
Term
|
Definition
| pegylated version of Epoetin Alfa |
|
|
Term
|
Definition
cytokine G-CSF drug major indicationf is for febrile neutropenia of chemotherapy, used to repopulate after bone marrow transplant |
|
|
Term
|
Definition
cytokine pegylated version of filgrastim |
|
|
Term
|
Definition
cytokine IL11, not a true platelet growth factor, but does promote growth of platelets used to prevent thrombocytopenia of chemotherapy |
|
|
Term
|
Definition
cytokine GM-CSF used only for myeloid reconstitution after bone marrow transplant |
|
|
Term
|
Definition
| used as anti-infectives and antineoplastics |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Chronic HepC and Chronic HepB |
|
|
Term
|
Definition
leukemias, melanoma, chronic HepC, chronic HepB, gential warts |
|
|
Term
|
Definition
|
|
Term
| Interferon Alpha-2B and Ribovarin |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| management of Multiple Sclerosis |
|
|
Term
| Interferon Beta-1A and Interferon Beta-1B |
|
Definition
|
|
Term
Type II Interferon Interferon Gamma-1B |
|
Definition
infections assoc. with chronic granulomatous disease activates macrophages malignant osteopetrosis |
|
|
Term
|
Definition
recombinant derivative of IL2 and is an IL-1R antagonist. indicated for renal carcinoma and melonoma many problems with pleiotropy |
|
|
Term
|
Definition
topical cytokine treatment of diabetic ulcers platelt derived growth factor |
|
|
Term
|
Definition
ANTI-cytokine IL-1R antagonist moderate to severe RA |
|
|
Term
|
Definition
|
|
